Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)

被引：18

作者：

Moran, Teresa ^{[1
]}

Quiroga, Vanesa ^{[1
]}

Llanos Gil, Maria de Los ^{[1
]}

Vila, Laia ^{[1
]}

Pardo, Nuria ^{[1
]}

Carcereny, Enric ^{[1
]}

Capdevila, Laia ^{[1
]}

Munoz-Marmol, Ana M. ^{[2
]}

Rosell, Rafael ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Catala Oncol Badalona, Med Oncol Dept, Carretera Canyet S-N, E-08193 Barcelona, Spain

[2] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Pathol Dept, E-08193 Barcelona, Spain

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2013年 / 2卷 / 02期

关键词：

D O I：

10.3978/j.issn.2218-6751.2013.03.04

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：128 / 141

页数：14

共 69 条

[51] Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis [J].

Shaw, Alice T. ;

Yeap, Beow Y. ;

Solomon, Benjamin J. ;

Riely, Gregory J. ;

Gainor, Justin ;

Engelman, Jeffrey A. ;

Shapiro, Geoffrey I. ;

Costa, Daniel B. ;

Ou, Sai-Hong I. ;

Butaney, Mohit ;

Salgia, Ravi ;

Maki, Robert G. ;

Varella-Garcia, Marileila ;

Doebele, Robert C. ;

Bang, Yung-Jue ;

Kulig, Kimary ;

Selaru, Paulina ;

Tang, Yiyun ;

Wilner, Keith D. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Iafrate, A. John ;

Camidge, D. Ross .

LANCET ONCOLOGY, 2011, 12 (11) :1004-1012

[52] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK [J].

Shaw, Alice T. ;

Yeap, Beow Y. ;

Mino-Kenudson, Mari ;

Digumarthy, Subba R. ;

Costa, Daniel B. ;

Heist, Rebecca S. ;

Solomon, Benjamin ;

Stubbs, Hannah ;

Admane, Sonal ;

McDermott, Ultan ;

Settleman, Jeffrey ;

Kobayashi, Susumu ;

Mark, Eugene J. ;

Rodig, Scott J. ;

Chirieac, Lucian R. ;

Kwak, Eunice L. ;

Lynch, Thomas J. ;

Iafrate, A. John .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4247-4253

[53]

Shaw AT, 2012, ANN ONCOL, V23

[54]

Shaw AT, 2012, ANN ONCOL S9, V23

[55] Erlotinib in previously treated non-small-cell lung cancer [J].

Shepherd, FA ;

Pereira, JR ;

Ciuleanu, T ;

Tan, EH ;

Hirsh, V ;

Thongprasert, S ;

Campos, D ;

Maoleekoonpiroj, S ;

Smylie, M ;

Martins, R ;

van Kooten, M ;

Dediu, M ;

Findlay, B ;

Tu, DS ;

Johnston, D ;

Bezjak, A ;

Clark, G ;

Santabárbara, P ;

Seymour, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132

[56] EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas [J].

Shinmura, Kazuya ;

Kageyama, Shinji ;

Tao, Hong ;

Bunai, Tornoyasu ;

Suzuki, Masaya ;

Kamo, Takaharu ;

Takamochi, Kazuya ;

Suzuki, Kazuya ;

Tanahashi, Masayuki ;

Niwa, Hiroshi ;

Ogawa, Hiroshi ;

Sugimura, Haruhiko .

LUNG CANCER, 2008, 61 (02) :163-169

[57] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[58] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J].

Soda, Manabu ;

Choi, Young Lim ;

Enomoto, Munehiro ;

Takada, Shuji ;

Yamashita, Yoshihiro ;

Ishikawa, Shunpei ;

Fujiwara, Shin-ichiro ;

Watanabe, Hideki ;

Kurashina, Kentaro ;

Hatanaka, Hisashi ;

Bando, Masashi ;

Ohno, Shoji ;

Ishikawa, Yuichi ;

Aburatani, Hiroyuki ;

Niki, Toshiro ;

Sohara, Yasunori ;

Sugiyama, Yukihiko ;

Mano, Hiroyuki .

NATURE, 2007, 448 (7153) :561-U3

[59] A mouse model for EML4-ALK-positive lung cancer [J].

Soda, Manabu ;

Takada, Shuji ;

Takeuchi, Kengo ;

Choi, Young Lim ;

Enomoto, Munehiro ;

Ueno, Toshihide ;

Haruta, Hidenori ;

Hamada, Toru ;

Yamashita, Yoshihiro ;

Ishikawa, Yuichi ;

Sugiyama, Yukihiko ;

Mano, Hiroyuki .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (50) :19893-19897

[60] Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway [J].

Souttou, B ;

Brunet-De Carvalho, N ;

Raulais, D ;

Vigny, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :9526-9531

← 1 2 3 4 5 6 7 →